80 FR 99 pgs. 29719-29720 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim
Type: NOTICEVolume: 80Number: 99Pages: 29719 - 29720
Pages: 29719, 29720Docket number: [Docket No. FDA-2011-N-0781]
FR document: [FR Doc. 2015-12402 Filed 5-21-15; 08:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0781]
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES:
Fax written comments on the collection of information by June 22, 2015.
ADDRESSES:
To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910-0428. Also include the FDA docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd.; COLE-14526, Silver Spring, MD 20993-0002 PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health
Claim-21 CFR 101.82(c)(2)(ii)(B)
OMB Control Number 0910-0428-Extension
[top] Section 403(r)(3)(A) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
In the Federal Register of March 10, 2015 (80 FR 12640), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.
We estimate the annual burden of this collection of information as follows:
21 CFR section | Number of respondents | Number of responses per respondent | Total annual responses | Average burden per response | Total hours |
---|---|---|---|---|---|
101.82(c)(2)(ii)(B) | 25 | 1 | 25 | 1 | 25 |
1 There are no capital costs or operating and maintenance costs associated with this collection of information. |
Based upon our experience with the use of health claims, we estimate that only about 25 firms would be likely to market products bearing a soy protein/coronary heart disease health claim and that only, perhaps, one of each firm's products might contain non-soy sources of protein along with soy protein. The records required to be retained by § 101.82(c)(2)(ii)(B) are the records, e.g., the formulation or recipe, that a manufacturer has and maintains as a normal course of its doing business. Thus, the burden to the food manufacturer is limited to assembling and retaining the records, which we estimate will take 1 hour annually.
Dated: May 15, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-12402 Filed 5-21-15; 08:45 am]
BILLING CODE 4164-01-P